Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1160.5000 -3.75 (-0.32%)
NSE Mar 28, 2025 15:31 PM
Volume: 691.4K
 

1160.50
-0.32%
BOB Capital Markets Ltd.
Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E
Promoters unpledged 2.56% of shares in last quarter. Total pledge stands at 17.83% of promoter holdings
More from Aurobindo Pharma Ltd.
All Rapid Results
Recommended